The Chancellor of the Exchequer has today (22 November) delivered the Government’s 2017 Budget.
BIVDA’s Chief Executive, Doris-Ann Williams MBE, has commented on some of the key announcements:
“The contribution of the life sciences sector to the prosperity of patients, the NHS and the UK economy is vital. BIVDA is pleased that the Government recognises the role our industry has to play in delivering innovation and growth.
“In vitro diagnostics (IVDs) are at the heart of the NHS and are used in approximately 70% of clinical decisions. Despite the differences they can make to patient pathways, a glass ceiling remains when it comes to adoption and uptake across the NHS.
“Therefore, we were delighted that the Chancellor has announced additional, much-needed funding for the health service. We hope that consideration is given to how IVDs can be better utilised to improve patient care and reduce pressure on NHS resources.
“At a time when the UK is looking to reaffirm its position as a world-leader in science and research, we welcome the measures in the Budget to attract skilled and talented researchers to the UK. The decision to further increase R&D spending and the R&D tax credit is also supported by industry.
“We look forward to working with the Government over the coming months to ensure the continuing success of the life sciences sector and to allow everyone to benefit from diagnosis-led healthcare”.
Notes to Editor:
BIVDA is the industry association for manufacturers and suppliers of IVD tests. We represent over 100 members, ranging from British start-up companies to UK subsidiaries of multinational corporations. BIVDA member companies employ more than 8,000 people in the UK, with total industry sales to the NHS of approximately £850 million.
For further information, please contact External Affairs Manager Emma Thomas at firstname.lastname@example.org or 0845 6188224.